About
He trained as a veterinary surgeon at the national veterinary school in Maisons-Alfort and earned an MBA at HEC Paris. He began at Roussel Uclaf in 1986 and later worked at Aventis in the United States. He joined Roche in 2006. Whoo also has a page for Thomas Schinecker, the current Roche CEO, and for David Ricks of Eli Lilly.
At Roche he became head of commercial operations in 2007, chief executive of Genentech in 2009, and chief operating officer of the Pharmaceuticals division in 2010.
Whoo compiled this page from public sources: AstraZeneca results release, 30 October 2026, Roche former executive profile, Wikipedia. It is not affiliated with or endorsed by Pascal Soriot. Are you Pascal Soriot? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-17. Photo: Virginia Office of the Governor, CC BY 4.0, via Wikimedia Commons.
Want a page like this? Create yours from your résumé.
Experience
Chief Executive Officer — AstraZeneca
2012 – Present
- Took the role on 1 October 2012
- Member of the Roche Corporate Executive Committee
- Led the Roche subsidiary
- Joined the enlarged Corporate Executive Committee
- Renamed Sanofi-Aventis USA in 2004
- Held finance, sales, and general management roles in Asia Pacific and Europe
Chief Operating Officer, Pharmaceuticals Division — Roche
2010 – 2012
Chief Executive Officer — Genentech
2009 – 2010
Head of Commercial Operations — Roche
2007 – 2009
Chief Operating Officer — Aventis USA
Before 2006
Various roles — Roussel Uclaf and Hoechst Marion Roussel
From 1986